Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dual Anti-Platelet Therapy”

47 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 47 results

Post-approval studies (Phase 4)Ended earlyNCT03224923
What this trial is testing

A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY)

Who this might be right for
Stable Coronary SyndromePercutaneous Coronary InterventionAntiplatelet Therapy+1 more
Ottawa Heart Institute Research Corporation 5
Large-scale testing (Phase 3)UnknownNCT01385319
What this trial is testing

Zotarolimus-eluting Endeavor Sprint Stent in Uncertain DES Candidates (ZEUS) Study

Who this might be right for
Coronary Artery Disease
Marco Valgimigli 1,606
Not applicableNot Yet RecruitingNCT07140133
What this trial is testing

Dual Anti-Platelet Optimized Stent for High Bleeding Risk Patient

Who this might be right for
High Bleeding Risk PatientsCardiologyStent Implantation+1 more
University Hospital, Grenoble 1,200
Post-approval studies (Phase 4)UnknownNCT03008083
What this trial is testing

Comparison Three vs Twelve Months of Dual Anti-Platelet Therapy After Stent Implantation

Who this might be right for
Drug-Eluting StentsPercutaneous Coronary Intervention
Shanghai MicroPort Medical (Group) Co., Ltd. 2,446
Not applicableStudy completedNCT05068414
What this trial is testing

Assessment of the Incidence of Hemorrhagic and Ischemic Events in Post-angioplasty in Anticoagulated Coronary Patients with Atrial Fibrillation

Who this might be right for
Atrial FibrillationAcute Coronary SyndromeThrombosis+1 more
Centre Hospitalier Universitaire de Nīmes 122
Not applicableStudy completedNCT01175200
What this trial is testing

Double the Dose of Clopidogrel or Switch to Prasugrel to Antagonize Proton Pump Inhibitor Interaction.

Who this might be right for
Anti Platelet Effects
Ascopharm Groupe Novasco 82
Post-approval studies (Phase 4)Study completedNCT03252249
What this trial is testing

Duration of Dual Anti-Platelet Therapy (DUAL-ACS)

Who this might be right for
Acute Coronary SyndromeCoronary Artery Disease
University of Edinburgh 5,094
Large-scale testing (Phase 3)Study completedNCT00269893
What this trial is testing

A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-platelet Therapy, in Patients Undergoing High-risk Coronary Angioplasty

Who this might be right for
Angina, UnstableAngioplasty, Transluminal, Percutaneous Coronary
Centocor, Inc. 2,038
Post-approval studies (Phase 4)Not Yet RecruitingNCT07736196
What this trial is testing

Aspirin-Free Strategy After 3-6 Month Dual Antiplatelet Therapy in Acute Coronary Syndrome

Who this might be right for
Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)Dual Anti-platelet Therapy
Assiut University 300
Post-approval studies (Phase 4)UnknownNCT03908593
What this trial is testing

Proton Pump Inhibitor Preventing Upper Gastrointestinal Injury In Patients On Dual Antiplatelet Therapy After CABG

Who this might be right for
Gastrointestinal Ulcer (Peptic) or ErosionAnti-Platelet TherapyCoronary Artery Bypass
Ruijin Hospital 232
Large-scale testing (Phase 3)Study completedNCT05070260
What this trial is testing

ACTISAVE: ACuTe Ischemic Stroke Study Evaluating Glenzocimab Used as Add-on Therapy Versus placEbo

Who this might be right for
Acute Ischemic Stroke
Acticor Biotech 438
Post-approval studies (Phase 4)Study completedNCT04483583
What this trial is testing

Tailoring P2Y12 Inhibiting Therapy in Patients Requiring Oral Anticoagulation After PCI

Who this might be right for
Coronary Artery Disease
University of Florida 81
Not applicableWithdrawnNCT06857045
What this trial is testing

Comparison Three vs Six Months of Dual Anti-platelet Therapy After Sirolimus-eluting Stent Implantation

Who this might be right for
Intracranial ArteriosclerosisIntracranial Artery StenosisDrug-Eluting Stents
Sino Medical Sciences Technology Inc.
Post-approval studies (Phase 4)Study completedNCT01659034
What this trial is testing

Short and Optimal Duration of Dual Antiplatelet Therapy Study

Who this might be right for
Coronary Artery Disease
Takeshi Morimoto 1,525
Not applicableUnknownNCT01233167
What this trial is testing

Effect of Different Anti-platelet Strategies on the Long-term Outcome After Sirolimus Drug-eluting Stent Implantation

Who this might be right for
Coronary Artery Disease
Sir Run Run Shaw Hospital 5,232
Large-scale testing (Phase 3)Study completedNCT00269880
What this trial is testing

A Study Comparing the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Combination With Two Different Heparin Regimens in Patients Undergoing Percutaneous Coronary Intervention.

Who this might be right for
Angioplasty, Transluminal, Percutaneous Coronary
Centocor, Inc. 2,792
Testing effectiveness (Phase 2)Active Not RecruitingNCT06199089
What this trial is testing

A Randomized, Double-blind, Placebo-controlled, and Multi-center Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 45
Not applicableEnded earlyNCT02224235
What this trial is testing

COBRA SHIELD OCT Study

Who this might be right for
Stable Angina
CeloNova BioSciences, Inc. 8
Not applicableStudy completedNCT01925794
What this trial is testing

COBRA PZF™ Coronary Stent for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term DAPT

Who this might be right for
Coronary Artery Disease
CeloNova BioSciences, Inc. 296
Testing effectiveness (Phase 2)Ended earlyNCT03606642
What this trial is testing

SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance and Dual Anti-Platelet Therapy

Who this might be right for
Coronary Artery DiseaseAtherosclerosisStent Placement
HonorHealth Research Institute 50
Next Page